PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
63.36
-1.55 (-2.39%)
Nov 12, 2026, 4:00 PM EST - Market closed
PTC Therapeutics Employees
PTC Therapeutics had 991 employees as of December 31, 2025. The number of employees increased by 52 or 5.54% compared to the previous year. That makes PTC Therapeutics the 14,970th largest employer in the world and 2,177th in the United States.
Employees
991
Change (1Y)
52
Growth (1Y)
5.54%
Revenue / Employee
$1,166,048
Profits / Employee
-$106,933
Market Cap
5.29B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 991 | 52 | 5.54% | 991 | 0 |
| Dec 31, 2024 | 939 | -116 | -11.00% | 939 | 0 |
| Dec 31, 2023 | 1,055 | -355 | -25.18% | 988 | 67 |
| Dec 31, 2022 | 1,410 | 233 | 19.80% | 1,402 | 8 |
| Dec 31, 2021 | 1,177 | 210 | 21.72% | 1,167 | 10 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ionis Pharmaceuticals | 1,480 |
| Travere Therapeutics | 497 |
| Mirum Pharmaceuticals | 470 |
| Scholar Rock Holding | 289 |
| Cogent Biosciences | 258 |
| Edgewise Therapeutics | 133 |
| Definium Therapeutics | 106 |
| Erasca | 103 |
PTCT News
- 9 days ago - PTC Therapeutics announces $500M share repurchase program - TheFly
- 9 days ago - PTC Therapeutics Board of Directors Authorizes $500 Million Share Repurchase Program - PRNewsWire
- 10 days ago - PTC Therapeutics to Participate in Upcoming Investor Conferences - PRNewsWire
- 10 days ago - PTC Therapeutics price target raised to $92 from $91 at JPMorgan - TheFly
- 10 days ago - PTC Therapeutics price target raised to $109 from $108 at Citi - TheFly
- 13 days ago - PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 13 days ago - PTC Therapeutics price target raised to $95 from $90 at TD Cowen - TheFly
- 14 days ago - PTC Therapeutics Earnings Call Transcript: Q3 2026 - Transcripts